Doctor's Notes

Hand Eczema in 1,004 Sarawak Healthcare Workers During COVID-19

Editorial illustration for Hand Eczema in 1,004 Sarawak Healthcare Workers During COVID-19 with Dr. Arsy #003 jar; fictional educational scene, not a patient or result.

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured scene is an AI-created illustration of fictional people and work settings. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.

Why this study is useful

This paper asks a focused question about work, daily activity or measurement. Keeping the population, denominator, design and timepoint visible prevents a useful result from becoming an exaggerated promise.

Study snapshot

Study element Reported detail
Population 1,004 healthcare workers at a tertiary hospital in Sarawak; 50.1% were nurses and 24.6% physicians
Design Cross-sectional questionnaire followed by clinical assessment of workers reporting hand changes
Timepoint During the COVID-19 pandemic, with one-year and point-prevalence windows
Key result One-year prevalence was 42.3% and point prevalence 16.5%; dry skin was reported by 368 and itch by 274, while atopic history and frequent washing were associated factors

What the numbers mean

One-year prevalence was 42.3% and point prevalence 16.5%; dry skin was reported by 368 and itch by 274, while atopic history and frequent washing were associated factors.

Important limitation: The design cannot establish causation, symptom reporting during an unusual pandemic period may not generalize, and clinical assessment was targeted to workers reporting changes rather than every participant.

Questionnaires, examinations, photographs, patch tests and administrative records answer different questions. A screening result can guide the next step, but it does not diagnose the cause of one person’s rash. An association can identify a pattern worth investigating, but it does not prove that a single task, material or personal factor caused every event.

Practical questions for a busy life

  • What exposure happens before symptoms: water, soap, gloves, friction, heat, dust, resin, adhesive or another material?
  • Which body sites are involved, and does the distribution match the suspected task or equipment?
  • What should be tracked: visible severity, sleep, daily function, missed work, presenteeism or safe participation?
  • Would occupational-health review, clinician examination or clinician-directed patch testing change the plan?
  • What requires prompt medical evaluation, including rapidly spreading redness, drainage, fever, severe pain or major loss of function?

Primary and authoritative sources

PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.

Where a cosmetic moisturizer fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.

Bottom line

The responsible conclusion is narrow: preserve the denominator, comparator, timepoint and limitations, then use the evidence to ask better clinical and exposure-control questions rather than promise a universal result.

DR. ARSY SKINCARE

Shop Moisturizer #003

Choose your preferred place to shop.

← Back to Doctor's Notes